Ointy CBN Cream is a topical formulation containing Beclometasone dipropionate (0.025% w/w), Neomycin sulfate (0.5% w/w), and Clotrimazole (1.0% w/w), designed for the treatment of inflammatory and infectious dermatological conditions. Beclometasone, a potent corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects, effectively reducing redness, swelling, and itching associated with various dermatoses. Neomycin, an aminoglycoside antibiotic, provides broad-spectrum antibacterial activity against susceptible gram-negative and some gram-positive bacteria, helping to prevent or treat secondary bacterial infections. Clotrimazole, an imidazole antifungal agent, inhibits ergosterol synthesis in fungal cell membranes, thereby combating dermatophytic and yeast infections such as candidiasis and tinea. The combination of these active ingredients makes Ointy CBN Cream suitable for managing mixed infections involving bacterial and fungal pathogens alongside inflammatory skin disorders. It is indicated for conditions like infected eczema, dermatitis, and fungal infections complicated by bacterial superinfection. Ointy CBN Cream should be applied topically as directed by a healthcare professional, avoiding prolonged use to minimize potential adverse effects such as skin atrophy, sensitization, or resistance development. Patients should consult a physician prior to use, particularly if pregnant, breastfeeding, or if symptoms persist.